Serum Ferritin Alone May Not Be Enough to Guide Treatment Decisions for Adult CRI Patients With IDA
Response to IV iron therapy in patients with mean serum ferritin levels >200 ng/mL14
The majority of patients had an Hgb response
KDOQI is a trademark of the National Kidney Foundation, Inc.
Now that you know about Iron-responsive Anemia, learn more about Functional IDA and IV Iron.
- In a clinical trial of non-dialysis patients with glomerular filtration rate (GFR) <60 mL/min (n=47),
98% had no evidence of iron deposits in the bone marrow, indicating severe iron deficiency14 - Nearly 90% of patients with elevated serum ferritin levels responded to intravenous (IV) iron therapy
with ferric gluconate14
Response to IV iron therapy in patients with mean serum ferritin levels >200 ng/mL14
The majority of patients had an Hgb response
- Nearly 70% of patients had an increase in Hgb of at least 1.0 g/dL14
- Approximately 50% of patients experienced an increase in Hgb of ≥2 g/dL
KDOQI™ Guidelines refer to patients with chronic renal insufficiency (CRI) as having chronic kidney disease (CKD), while others refer to them as having end-stage renal disease (ESRD) in more severe cases. CKD, CRI, and ESRD all refer to kidney disease.
IDA=iron deficiency anemia; KDOQI=National Kidney Foundation Kidney Disease Outcomes Quality Initiative.KDOQI is a trademark of the National Kidney Foundation, Inc.
Now that you know about Iron-responsive Anemia, learn more about Functional IDA and IV Iron.
